Literature DB >> 1957546

Regression of atherosclerosis. Benefit can be expected from low LDL-C and high HDL-C levels.

A C Arntzenius.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1957546

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN： 0001-5385            Impact factor:   1.718


× No keyword cloud information.
  4 in total

1.  Oral supplement of six selective amino acids arrest progression renal failure in uremic patients.

Authors:  Hippocrates Yatzidis
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

Review 2.  Endurance training, cardiovascular function and the aged.

Authors:  J S Green; S F Crouse
Journal:  Sports Med       Date:  1993-11       Impact factor: 11.136

3.  Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis.

Authors:  S Ye; G F Watts; S Mandalia; S E Humphries; A M Henney
Journal:  Br Heart J       Date:  1995-03

Review 4.  Gemfibrozil. A reappraisal of its pharmacological properties and place in the management of dyslipidaemia.

Authors:  C M Spencer; L B Barradell
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.